Latest news with #Inflexion
Fashion Network
4 hours ago
- Business
- Fashion Network
L'Oreal expands dermatological skincare portfolio with Medik8 deal
L'Oreal will acquire British skincare brand Medik8, Britain-based private equity firm Inflexion said on Monday, as the French cosmetics giant boosts its offering in the fast-growing dermatological skincare market. Neither party disclosed the size of the deal. Medik8 produces vitamin A-based anti-aging creams and serums. "The partnership with L'Oreal will allow Medik8 to deepen its presence in existing markets and expand globally. As part of the transaction, Inflexion will retain a minority shareholding in Medik8," the private equity firm said in a statement. L'Oreal's dermatological beauty division, which includes major brands like CeraVe, La Roche-Posay and SkinCeuticals, has remained its fastest-growing unit in recent years. The division generated 7 billion euros ($7.99 billion) in revenue last year, marking a growth of nearly 10% compared to the previous year. The business also delivers the highest profit margin among L'Oreal's four divisions. Consumer interest in science-backed products has driven the division's growth, though rising competition has recently slowed that momentum. L'Oreal executives said this year they are pursuing acquisitions to revive slowing growth. The company acquired Korean skincare brand Dr.G in December and also bought a minority stake in Oman-based perfume house Amouage last year. ($1 = 0.8757 euros)
Fashion Network
5 hours ago
- Business
- Fashion Network
L'Oreal expands dermatological skincare portfolio with Medik8 deal
L'Oreal will acquire British skincare brand Medik8, Britain-based private equity firm Inflexion said on Monday, as the French cosmetics giant boosts its offering in the fast-growing dermatological skincare market. Neither party disclosed the size of the deal. Medik8 produces vitamin A-based anti-aging creams and serums. "The partnership with L'Oreal will allow Medik8 to deepen its presence in existing markets and expand globally. As part of the transaction, Inflexion will retain a minority shareholding in Medik8," the private equity firm said in a statement. L'Oreal's dermatological beauty division, which includes major brands like CeraVe, La Roche-Posay and SkinCeuticals, has remained its fastest-growing unit in recent years. The division generated 7 billion euros ($7.99 billion) in revenue last year, marking a growth of nearly 10% compared to the previous year. The business also delivers the highest profit margin among L'Oreal's four divisions. Consumer interest in science-backed products has driven the division's growth, though rising competition has recently slowed that momentum. L'Oreal executives said this year they are pursuing acquisitions to revive slowing growth. The company acquired Korean skincare brand Dr.G in December and also bought a minority stake in Oman-based perfume house Amouage last year. ($1 = 0.8757 euros)
Fashion Network
5 hours ago
- Business
- Fashion Network
L'Oreal expands dermatological skincare portfolio with Medik8 deal
L'Oreal will acquire British skincare brand Medik8, Britain-based private equity firm Inflexion said on Monday, as the French cosmetics giant boosts its offering in the fast-growing dermatological skincare market. Neither party disclosed the size of the deal. Medik8 produces vitamin A-based anti-ageing creams and serums. "The partnership with L'Oreal will allow Medik8 to deepen its presence in existing markets and expand globally. As part of the transaction, Inflexion will retain a minority shareholding in Medik8," the private equity firm said in a statement. L'Oreal's dermatological beauty division, which includes major brands like CeraVe, La Roche-Posay and SkinCeuticals, has remained its fastest-growing unit in recent years. The division generated 7 billion euros ($7.99 billion) in revenue last year, marking a growth of nearly 10% compared to the previous year. The business also delivers the highest profit margin among L'Oreal's four divisions. Consumer interest in science-backed products has driven the division's growth, though rising competition has recently slowed that momentum. L'Oreal executives said this year they are pursuing acquisitions to revive slowing growth. The company acquired Korean skincare brand Dr.G in December and also bought a minority stake in Oman-based perfume house Amouage last year. © Thomson Reuters 2025 All rights reserved.
Time of India
6 hours ago
- Business
- Time of India
L'Oreal buys British skincare brand Medik8
L'Oreal is to acquire British skincare brand Medik8 , its owner, Britain-based private equity firm Inflexion, said on Monday, boosting the French cosmetics giant's offering in the fast-growing dermatological skincare market . The size of the deal was not disclosed. Medik8 focuses on vitamin A-based anti-ageing creams and serums. "The partnership with L'Oreal will allow Medik8 to deepen its presence in existing markets and expand globally. As part of the transaction, Inflexion will retain a minority shareholding in Medik8," the private equity firm said in a statement. L'Oreal's dermatological beauty division, which includes major brands like CeraVe, La Roche-Posay, and SkinCeuticals, has been its fastest growing in recent years, reaching revenues of 7 billion euros (USD 7.99 billion) last year, after growing almost 10% on the year before. The business, which also has the highest profit margin among its four divisions, has boomed on growing consumer interest in science-backed products, though growth has slowed recently due to rising competition. L'Oreal executives said this year they were pursuing acquisitions and looking to revive flagging growth. The company acquired Korean skincare brand, Dr.G, in December and also bought a minority stake in Oman-based perfume house Amourage last year.
Irish Examiner
6 hours ago
- Business
- Irish Examiner
Because it's worth it: L'Oreal to buy skincare brand Medik8 in €1bn deal
L'Oreal has agreed to buy a majority stake in the UK company Medik8 as the French cosmetics group strengthens its presence in the booming skincare market. The private equity firm Inflexion will keep a minority stake as part of the deal while the current management will stay on, L'Oreal said on Monday without disclosing financial details. L'Oreal has been boosting its portfolio, seeking to take advantage of the interest in skincare driven by social media influencers who use and promote creams and serums on platforms like TikTok. The Financial Times reported last week that the deal was worth roughly €1bn. L'Oreal shares fell less than 1% in early Paris trading. They have rebounded about 11% so far this year after a slowdown in the US and China weighed on the stock in 2024. Medik8, founded in 2009 by Elliot Isaacs and based just north of London, specializes in anti-aging treatments. It will join L'Oreal's luxury division. Inflexion bought Medik8 for an undisclosed amount in 2021. The brand's founder, Mr Isaacs, will remain on the board of Medik8, L'Oreal said. The deal gives L'Oreal a wider offering in skincare at different prices. Medik8 products are typically more affordable than SkinCeuticals, which L'Oreal bought two decades ago and is now part of its dermatological beauty unit. Cyril Chapuy, who heads the group's luxury division, highlighted Medik8's 'accessible price point'. The dermatological beauty unit saw the fastest growth among L'Oreal's four divisions last year. The unit also includes affordable brands like CeraVe and Vichy. The group also bought Australian cosmetics brand Aesop in 2023 to strengthen the luxury division, which is the second-largest in sales after the consumer-products unit. Other well-known L'Oreal brands include mascara maker Maybelline New York and shampoo labels Garnier and Kérastase. The company in April reported stronger-than-expected sales in the first part of the year, led by demand for high-end make-up and perfumes. Bloomberg
